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The role of retinal microglial cells (MCs) in age-related macular degeneration (AMD) is unclear. Here we dem-
onstrated that all retinal MCs express CX3C chemokine receptor 1 (CX3CR1) and that homozygosity for the 
CX3CR1 M280 allele, which is associated with impaired cell migration, increases the risk of AMD. In humans 
with AMD, MCs accumulated in the subretinal space at sites of retinal degeneration and choroidal neovascu-
larization (CNV). In CX3CR1-deficient mice, MCs accumulated subretinally with age and albino background 
and after laser impact preceding retinal degeneration. Raising the albino mice in the dark prevented both 
events. The appearance of lipid-bloated subretinal MCs was drusen-like on funduscopy of senescent mice, and 
CX3CR1-dependent MC accumulation was associated with an exacerbation of experimental CNV. These results 
show that CX3CR1-dependent accumulation of subretinal MCs evokes cardinal features of AMD. These find-
ings reveal what we believe to be a novel pathogenic process with important implications for the development 
of new therapies for AMD.
Introduction
Age-related macular degeneration (AMD) is the leading cause of 
vision loss in elderly people in the industrialized countries (1). 
Its most prominent pathologic features are lesions involving the 
retinal pigment epithelium (RPE) and Bruch’s membrane (BM), 
photoreceptor degeneration (2), and, in the most aggressive cases, 
choroidal neovascularization (CNV). Early AMD is characterized 
by yellowish-white dots called drusen, located on BM, partially 
covered by the RPE and clinically visible with funduscopy (3). 
Composed of lipids and glycoproteins (4), drusen are believed to 
be formed by extracellular deposit of materials or by transformed 
degenerating RPE cells (5). Controversy continues to surround 
their pathogenesis, as well as the causes of AMD.
Epidemiological studies have helped to identify key factors 
in the pathogenesis of AMD. Age (1) and family history (3) are 
the principal predisposing factors. Genes with polymorphisms 
associated with AMD include apolipoprotein E (6), superoxide 
dismutase (7), complement factor H (8, 9), and CX3C cheomkine 
receptor 1 (CX3CR1) (10).
Some of the features of human AMD have been observed in 
transgenic mouse models. Notably, a deficiency in macrophage 
recruitment through a CC chemokine ligand 2– (CCL2-) and CC 
chemokine receptor 2–dependent (CCR2-dependent) pathway 
from the choroidal circulation may prevent the clearance of accu-
mulating debris in BM; this has been proposed as a mechanism 
for drusen genesis (11). Moreover, CCL2- and CCR2-dependent 
macrophage recruitment has previously been shown to participate 
in CNV development (12). Studying the expression of the chemo-
kine receptors CCR2 and CX3CR1 (receptor for CX3C chemo-
kine ligand 1; CX3CL1) identifies 2 functional subsets of murine 
blood monocytes: inflammatory monocytes, which express both 
receptors, and noninflammatory monocytes, which express only 
CX3CR1 (13). Microglial cells (MCs) express CX3CR1 and play a 
role in controlling microglial neurotoxicity in the brain (14). We 
postulated that CX3CR1 is expressed on MCs in the photorecep-
tor layer in AMD (15) and participates in AMD development and 
progression by controlling retinal MC redistribution. Accordingly, 
we analyzed CX3CR1 polymorphisms and expression in human 
AMD and studied the eyes of 2 independently generated CX3CR1 
knockout mouse strains in aging- and laser-induced CNV. We 
found that CX3CR1 invalidation led to subretinal MC (SrMC) 
accumulation, which was associated with drusen-like lesions, reti-
nal degeneration, and exacerbated neovascularization, cardinal 
features of AMD.
Results
CX3CR1 polymorphism and AMD. To evaluate the role of the che-
mokine receptor CX3CR1 in AMD, we studied the distribution of 
2 previously reported variants of CX3CR1 (T280M and V249I) in 
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a sample of elderly individuals with AMD (Genetics of Age-related 
Macular Degeneration study; GAMD; Table 1 and Supplemental 
Table 1; supplemental material available online with this article; 
doi:10.1172/JCI31692DS1). The frequencies of CX3CR1 polymor-
phisms did not deviate from Hardy-Weinberg equilibrium among 
AMD cases or subjects from reference studies (data not shown). 
Table 1 shows the distribution of the CX3CR1 T280M genotypes 
among the subjects from the DETER study (P. Deterre, unpublished 
observations) and the previously published Etude Cas-Témoin de 
l’Infarctus du Myocarde (ECTIM; ref. 16), Offspring Cohort of the 
Framingham Heart Study (FHS; ref. 17), and Étude du Profil Géné-
tique de l’Infarctus Cérébral (GENIC; ref. 18) studies used as ref-
erences. Homozygosity for the M280 allele was consistently more 
frequent in studies of AMD than of other diseases. Odds ratios 
associated with homozygosity for the rare allele were therefore com-
puted with genotypes carrying the more frequent allele as the refer-
ence groups. M280 homozygosity was associated with an increased 
risk of AMD, with odds ratios ranging from 1.97 to 2.695 (95% con-
fidence intervals, 1.069–3.652 and 1.268–5.728, respectively). This 
association was independent of age, and disease severity was not 
associated with the polymorphism. The similarity of the genotype 
distribution of the CX3CR1 V249I alleles among AMD patients and 
subjects from reference studies (Supplemental Table 1) indicated 
that this polymorphism had no significant effect on AMD risk.
CX3CR1 expression in AMD. To understand the mechanism by which 
CX3CR1 alterations may contribute to AMD development, we ana-
lyzed CX3CR1 expression in eyes of healthy donors and subjects with 
AMD (Figure 1). CX3CR1 positivity (red staining) was found in cells 
of the inner retina. Double labeling for CX3CR1 (green fluorescence) 
and the vascular endothelial cell marker ulex (red fluorescence) 
showed the ramified morphology of cells expressing CX3CR1 and 
their closeness to the retinal vasculature in the healthy eye (Figure 1A, 
inset). No CX3CR1 positivity was detected in photoreceptors or RPE 
cells in healthy donor eyes. In the macula of age-matched patients 
with AMD, we observed localized RPE disruption and clumping as 
well as photoreceptor degeneration (Figure 1B). In the affected zones, 
CX3CR1-positive cells were found ectopically in the outer retina and 
in the subretinal space, as well as in the perivascular retinal MCs in 
the inner retina (Figure 1B). Some of these cells in the outer retina 
were very large and bloated (Figure 1B, inset).
All CX3CR1-positive cells (Figure 1C) 
overlapped precisely with cells express-
ing the microglial marker CD18 (Figure 
1D), and vice versa (Figure 1E). Further-
more, CX3CR1 deposits were found in 
drusen, specifically in the CD18-positive 
dendritic cells interposed between the 
choroidal vessels (Figure 1F). CX3CR1-
positive cells were also found in close 
contact with CNV (Figure 1G).
The M280 polymorphism leads to migra-
tional defect. We previously showed that 
only the membrane-anchored form 
of CX3CL1 functionally discrimi-
nates between the 2 allelic isoforms 
of CX3CR1 (19): monocytes bearing 
the CX3CR1-IM allele adhere more 
strongly than cells expressing only the 
CX3CR1-VT variant. In contrast, their 
chemotactic response to CX3CL1 does 
not distinguish between the 2 monocyte populations. To gain 
insight into the ability of cells expressing different variants of 
CX3CR1 to migrate in response to chemoattractants present in 
the retina, we studied the in vitro chemotaxis of monocytes in 
response to CCL2 through porous membranes with and without 
a CX3CL1 coating. Monocytes from individuals homozygous for 
the CX3CR1-VT or CX3CR1-IM isoforms migrated equally well 
to CCL2 (Figure 2A). CCL2-specific chemotactic responses of 
monocytes from individuals homozygous for the VT variant were 
similar whether or not the filter-bound CX3CR1 was present (Fig-
ure 2A), with chemotactic index ratios (index without CX3CL1/
index with CX3CL1) of 1.1 ± 0.1. In contrast, monocytes from 
individuals homozygous for CX3CR1-IM variants migrated in 
smaller numbers to the lower chamber in response to CCL2 when 
anchored CX3CL1 was present than when it was not (Figure 2A). 
This inhibition reached 48% ± 11% (Figure 2B). These data are con-
sistent with our previous work (19) and indicate that chemotaxis 
of monocytes from individuals with IM genotypes is impaired in 
the presence of bound CX3CL1.
SrMCs accumulate in CX3CR1–/– mice with age and develop retinal 
degeneration. Because CX3CR1 was expressed on human MC (Fig-
ure 1) and because a CX3CR1 polymorphism that impairs cell 
migration was associated with risk of AMD (Table 1 and ref. 10), 
we explored the role of CX3CR1 in retinal homeostasis using 
mice deficient in CX3CR1 gene (20). We first identified the site of 
CX3CR1 expression by using CX3CR1GFP/GFP (CX3CR1-deficient 
with GFP driven by CX3CR1 promoter) and CX3CR1+/GFP mice of 
different ages. In 18-month-old CX3CR1+/GFP and CX3CR1GFP/GFP 
mice, GFP-positive cells abutted retinal endothelial cells (red 
fluorescence, BSA-1; Figure 3, A and B). Confocal images of the 
outer plexiform layer of retinal flatmounts displayed dense net-
works of ramified MCs of similar density in CX3CR1+/GFP and 
CX3CR1GFP/GFP animals (266 ± 19 and 305 ± 27 MCs/mm2; n = 4 
per group; Figure 3, C and D), indicating that all MCs expressed 
CX3CR1 and that homing of retinal MCs was CX3CR1 indepen-
dent. The expression of the reporter gene in individual MCs was 
similar in CX3CR1+/GFP and CX3CR1GFP/GFP mice. The absence 
of CX3CR1 expression in neurons, astrocytes, Müller cells, and 
RPE demonstrated that MCs were the only CX3CR1-posititive 
cells in the retina.
Table 1
Distribution of CX3CR1 T280M in GAMD and reference studies
   Study (N)
Distribution GAMD (284) DETER (520) ECTIM (2,212) FHS (1,859) GENIC (929)
TT (no.) 64.1% (182) 76.0% (395) 68.9% (1,523) 67.5% (1,254) 70.2% (652)
TM (no.) 29.9% (85) 21.7% (113) 28.5% (631) 29.6% (550) 26.7% (248)
MM (no.) 6.0% (17) 2.3% (12) 2.6% (58) 3.0% (55) 3.1% (29)
FrequencyA 0.21 0.13 0.17 0.18 0.16
P – 0.0098 0.0033 0.0139 0.033
Odds ratio (95% – 2.695 2.365 2.088 1.976 
confidence interval)  (1.268 to 5.728) (1.357 to 4.121) (1.194 to 3.652) (1.069 to 3.652)
Distribution of patients homozygous for threonine (TT) and methionine (MM), common and rare alleles, 
respectively, at position 280, as well as patients heterozygous for threonine/methionine (TM) at position 
280. N, total number of participants. AAllelic frequency of allele M. P values and odds ratios were deter-
mined by comparing the frequency of the MM genotype with the frequency of T carriers. The DETER 
(P. Deterre, unpublished observations), ECTIM (16), FHS (17), and GENIC (18) studies were used as 
reference studies.
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On RPE flatmounts of 18-month-old CX3CR1+/GFP mice (Fig-
ure 3E), GFP-positive SrMCs were seen occasionally, as previously 
reported (21), whereas in CX3CR1GFP/GFP mice, SrMCs juxtaposed 
to RPE (Figure 3B, arrows) accumulated markedly (Figure 3F) 
as a function of age (Figure 3G). In CX3CR1–/– mice without the 
GFP transgene, CD11b-positive SrMCs accumulated in a manner 
similar to that of the analogous CX3CR1GFP/GFP animals (data not 
shown). Histological sections of 18-month-old CX3CR1+/+ (Figure 
3H) and CX3CR1–/– (Figure 3I) mice revealed substantial degenera-
tion of the outer retina in the knockout mice. Measurements of 
the photoreceptor cell layer showed significant thinning (40%) in 
CX3CR1–/– mice (Figure 3J).
SrMC accumulation is associated with retinal degeneration in albino 
CX3CR1–/– mice. Light has been suggested to be a contributing fac-
tor in the genesis of AMD (22). In conventional light conditions in 
wild-type albino animals, SrMCs accumulate as a function of ambi-
ent light intensity; this accretion is inhibited by light restriction 
(21). Accordingly, we found that 1-month-old CX3CR1+/+ albino 
mice raised in normal light conditions (12-h light/12-h dark cycle) 
exhibited some CD11b-positive SrMCs (green fluorescence) adja-
cent to the RPE (phalloidin red fluorescence; Figure 4A), but these 
were significantly more abundant in age-matched CX3CR1–/– mice 
(Figure 4B). The number of SrMC increased as a function of age in 
wild-type and knockout mice, but the accumulation was accentu-
ated in the latter (Figure 4C). Moreover, the CX3CR1–/– BALB/c 
mice housed in complete darkness throughout the experiment 
accumulated significantly fewer SrMCs at 2 months than did the 
CX3CR1–/– mice raised in ambient light (Figure 4C).
Histological sections of 4-month-old CX3CR1+/+ (Figure 4D) 
and CX3CR1–/– (Figure 4E) mice showed marked degeneration of 
the outer retina in the latter; this degeneration was not observed 
in the dark-raised knockout mice (Figure 4F). Quantification of 
photoreceptor cell layer thickness showed a slight (20%) but sig-
nificant thinning at 2 months and complete degeneration at 4 
months in the knockout mice, both of which were prevented by 
light restriction (Figure 4G).
Figure 1
CX3CR1 expression in AMD. (A) CX3CR1 (fast red labeling) was 
expressed in the inner retina (arrows); no CX3CR1-positive cells were 
found in the outer nuclear layer (ONL), photoreceptor OSs, or RPE. 
Inset: Confocal images of the nerve fiber layer of double-labeled reti-
nal flatmounts showed the ramified morphology of cells expressing 
CX3CR1 (green) and their close proximity to the retinal vasculature 
(Ulex red) in a healthy eye. (B) In affected zones of the macula of 
age-matched subjects with AMD, additional CX3CR1-positive cells 
(arrows) were found in and below the outer nuclear layer that con-
tains the photoreceptors. Inset: These cells were large and bloated 
(green, CX3CR1; blue, DAPI). (C–E) CX3CR1-expressing cells (C) 
were ramified cells that also labeled positive for the MC marker CD18 
(red, D); merged image is shown in E. (F) Drusen contained acel-
lular CX3CR1 deposits (arrows). (G) CX3CR1-positive cells were in 
close physical contact with CNV (arrows). Results are representative 
for immunohistochemistry from 4 eyes with AMD and 3 age-matched 
control eyes. INL, inner nuclear layer; IPL, inner plexiform layer. Scale 
bar: 50 μm (A–G and A, inset); 20 μm (B, inset).
Figure 2
The M280 polymorphism leads to CX3CR1 dysfunction and impaired 
migration. (A) Representative CCL2-dependent migration through 
CX3CL1-coated filters of monocytes from individuals homozygous for 
the 2 extreme haplotypes of CX3CR1 (VT and IM). Flow cytometry 
was used to count the number of CD14-positive cells that migrated 
into the lower chamber. Each data point is the mean ± SEM of 3 dif-
ferent determinations. (B) Genetic variations of CX3CR1-impaired 
CCL2-dependent migration through filters coated with CX3CL1. 
Monocytes from individuals homozygous for CX3CR1-IM variants 
(n = 5) have less CCL2-dependent chemotactic ability in the presence 
of a CX3CL1-coated filter than do monocytes from individuals homo-
zygous for CX3CR1-VT variants (n = 8). Migration ability is expressed 
as the ratio of the chemotactic index (CI) in response to CCL2 of 
monocytes migrating through a filter with or without a CX3CL1 coating 
(chemotactic index without CX3CL1 relative to chemotactic index with 
CX3CL1). ***P = 0.0006.
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Drusen observed in CX3CR1 knockout mice are lipid-bloated SrMCs. 
Subretinal deposits are characteristic in AMD. Funduscopy of 
senescent CX3CR1+/+ (Figure 5A) and CX3CR1–/– (Figure 5B) mice 
showed that all the CX3CR1–/– mice had numerous drusen-like 
yellow nodular deposits in the deep layer of the retina that were 
not present in age-matched CX3CR1+/+ or 2-month-old CX3CR1–/– 
mice (data not shown). Similar features were observed in a second 
strain of CX3CR1 knockout mouse, CX3CR1GFP/GFP (23). To char-
acterize in more detail the anatomical structure that produced 
this drusen-like appearance under funduscopy in CX3CR1–/– mice, 
we flatmounted the eyes after removal of the neuroretina, thus 
exposing the RPE monolayer. The RPE monolayer of CX3CR1+/+ 
animals, observed in tangential white light, appeared regular and 
smooth (Figure 5C). In contrast, in knockout mice, examination 
of the monolayer showed it was abutted by multiple elevated 
white spots (Figure 5D). Higher magnifica-
tion revealed the intracellular location of this 
white material: bloated cells adjacent to the 
RPE cell monolayer. These intracellular yel-
lowish-white deposits were present only in 
GFP-positive cells (Figure 5, E–G). Further 
confocal microscopy of these GFP-positive 
ramified cells (Figure 5H) used the specific 
MC marker 5D4 (22) (Figure 5I) and CD11b 
or F4/80 (data not shown) to identify these 
cells as activated SrMCs. Not all SrMCs were 
bloated, but only the bloated cells appeared 
drusen-like on RPE flatmounts.
The presence of yellowish-white deposits 
in 5D4-, CD11b- and F4/80-positive SrMCs 
was corroborated in CX3CR1–/– eyes (data not 
shown). Histological sections of 12-month-old 
CX3CR1+/+ (Figure 3J) and CX3CR1–/– (Figure 
5K) mice showed subretinal cells adhering 
to the pigmented monolayer of the RPE in 
CX3CR1–/– but not CX3CR1+/+ mice. Ultra-
structural analysis of senescent CX3CR1–/– 
eyes by transmission electron microscopy con-
firmed the presence of subretinal cells between 
the outer segment (OS) and the RPE cells (Fig-
ure 5L), which contained intracellular lipid 
deposits and remnants of OS (Figure 5M), as 
typically observed in RPE cells (24). Rhodopsin 
immunoreactivity in CD11b-positive SrMCs 
of CX3CR1–/– RPE flatmounts (Figure 5N) was 
consistent with ingestion of OS by SrMCs.
SrMC accumulation is associated with CNV 
and retinal degeneration in CX3CR1 knockout 
mice. Laser coagulation of the mouse choroid 
induces a local inflammatory reaction com-
posed of blood-derived macrophages and 
activated MCs (25). After detecting SrMC 
accumulation in senescent and ambient 
light–exposed CX3CR1-deficient mice, we 
studied the influence of CX3CR1 deficiency 
in laser injury. Fourteen days after a laser 
injury, CX3CR1+/GFP mice showed some GFP-
positive SrMCs adjacent to the choroid scar 
(Figure 6A), but many more such cells had 
accumulated in the CX3CR1GFP/GFP mice (Fig-
ure 6B) at this stage. The cell counts after laser impact (Figure 6C) 
showed a transient increase in the CX3CR1+/GFP mice, peaking at 
day 7; again, the increase in CX3CR1GFP/GFP mice was significantly 
higher and continued to rise. Immunohistochemistry at day 7 in 
CX3CR1+/+ mice (Figure 6, D–F) revealed that the proangiogenic 
factor VEGF (Figure 6D) was produced by activated SrMCs that 
expressed F4/80 (Figure 6, E and F).
At 14 days after laser injury, there was significantly less CNV in 
CX3CR1+/+ mice (Figure 6G) than in their CX3CR1–/– counterparts 
(Figure 6H). Quantification of the surface covered by the endothelial 
cells showed twice as much neovascularization in the CX3CR1–/– and 
CX3CR1GFP/GFP knockout strains (Figure 6I) than their controls.
Finally, because retinal degeneration worsens secondary to sub-
retinal neovascularization in AMD, we tested whether the increased 
MC recruitment in the vicinity of the subretinal neovascularization 
Figure 3
SrMCs accumulate in CX3CR1–/– C57BL/6 mice with age and lead to retinal degeneration. 
(A) Sections from an 18-month-old CX3CR1+/GFP mouse showed GFP-positive cells in close 
proximity to Griffonia simplicifolia–positive (red) retinal endothelial cells. (B) Sections from 
an 18-month-old CX3CR1GFP/GFP mouse revealed the same distribution of GFP-positive cells 
in the inner retina but showed additional subretinal GFP-positive cells juxtaposed to the RPE 
cell layer (arrows). (C and D) Confocal images of the outer plexiform layer revealed that the 
entire network of ramified MCs was GFP positive and similarly dense in CX3CR1+/GFP (C) and 
CX3CR1GFP/GFP mice (D). (E and F) RPE flatmounts of aged mice showed a strong accumula-
tion of SrMCs in CX3CR1+/GFP (E) and CX3CR1GFP/GFP mice (F). (G) Quantification of subreti-
nal GFP-positive cells on RPE flatmounts revealed that SrMCs accumulated progressively in 
CX3CR1GFP/GFP mice and were significantly more numerous than in CX3CR1+/GFP mice at all 
time points. (H and I) Toluidine blue–stained epoxy retinal semithin sections showed degen-
eration of photoreceptors in 18-month-old CX3CR1–/– (I) mice compared with CX3CR1+/+ (H) 
mice. (J) Measurements of photoreceptor cell layer thickness showed significant thinning of 
the photoreceptor cell layer in CX3CR1–/– mice compared with CX3CR1+/+ mice. Experiments 
were performed on 4–8 eyes from different mice per group. *P < 0.05. Ch, choroid. ROS, rod 
OS. Scale bars: 50 μm.
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was associated with an aggravation of the retinal degeneration. In 
12-month-old animals, in which a 30% reduction in outer nuclear 
layer thickness was observed in CX3CR1–/– compared with 
CX3CR1+/+ mice, we analyzed the photoreceptor cell layer at 21 days 
after the laser treatment. In CX3CR1+/+ mice, photoreceptor cell layer 
thickness adjacent (200 μm) to the laser-induced retinal destruction 
did not differ significantly from that in the nonimpacted retina (Fig-
ure 6J). In contrast, under these conditions, the photoreceptor layer 
had thinned substantially in CX3CR1–/– mice (Figure 6K). This dif-
ference may result from the combination of age- and laser-induced 
degeneration. To evaluate the laser-induced alteration, the relative 
retinal thicknesses of injured and uninjured retina were compared 
at different distances from the laser impact (ranging 100–1,000 μm). 
Laser-dependent retinal degeneration was significantly more pro-
nounced in CX3CR1–/– mice than in CX3CR1+/+ mice at distances of 
100 and 200 μm but not at 300 and 400 μm (Figure 6L).
Discussion
Here we show that retinal MCs all and invariably expressed 
CX3CR1, that these cells accumulated subretinally in AMD, and 
that the T280M polymorphism of CX3CR1 was associated with 
both impaired cell migration and AMD. MCs accumulated under 
the retinas of CX3CR1-deficient mice with age, after laser injury, 
or with albino background. This accumulation elicited photore-
ceptor degeneration and exacerbated neovasculariza-
tion. Moreover, the resulting prolonged contact of MC 
with lipid-rich OS was associated with intracellular 
lipid accumulation in the MCs. Surprisingly, these sub-
retinal microglial foam cells turned out to be the origin 
of drusen-like deposits in mice. Our results show that 
accumulation of MCs in the subretinal space may be a 
driving force in the pathogenesis of AMD, rather than a 
secondary occurrence.
Our study of patients with AMD showed that homozy-
gosity for the M280 allele was consistently more frequent 
in groups with AMD than in studies of other populations 
and confirmed a previous report (10) of a dominant asso-
ciation between the CX3CR1 M280 allele and AMD risk. 
Subjects in the control studies were not checked for AMD, 
and some certainly had or will develop the disease. The 
effect of this bias, however, should be an underestimation 
of the impact of CX3CR1 polymorphisms on AMD risk. 
These data indicate that the chemokine receptor CX3CR1 
may play an important role in AMD pathogenesis.
To understand how CX3CR1 polymorphisms con-
tribute to AMD pathogenesis, it is essential to identify 
the types of cells expressing CX3CR1 in the retina. Our 
immunohistochemical analysis in humans showed that 
CX3CR1 was expressed on all retinal MCs, which were 
identified by their morphology and CD18 expression. In 
addition, experiments using CX3CR1+/GFP mice and the 
murine MC markers CD11b, F4/80, and 5D4 confirmed 
that only MCs express CX3CR1. Using both techniques 
in 2 different species, we found no CX3CR1 expression 
in neurons, astrocytes or glial cells: as a previous report 
showed for the CNS (14), MCs are the only cells in the 
retina that express CX3CR1. Contrary to a previous 
report (10), when we used the CX3CR1-specific antibody 
revealed by the fast red system to circumvent autofluo-
rescence interference and conducted experiments with 
a reporter gene, we failed to find significant CX3CR1 expression in 
RPE cells. In AMD, CX3CR1-positive MCs accumulated subreti-
nally in affected areas of the macula. Our data are consistent with 
the infiltration of the subretinal space by activated MCs previously 
described in AMD (15) and indicate that a specific inflammatory 
environment characterized by production of specific cytokines and 
chemokines may determine particular pathological conditions.
Cells of the CNS and of the retina express CX3CL1 abundantly 
(26, 27). On the other hand, RPE cells under oxidative stress express 
other monocyte chemoattractant chemokines such as CCL2 (28), 
which may be responsible for the recruitment of MCs in the sub-
retinal space. To evaluate the effect of the M280 polymorphism 
on cell migration in a CX3CL1-rich environment, we tested 
M280 CX3CR1 monocyte migration through a CX3CL1-coated 
porous membrane in response to CCL2. Previous studies show 
that the M280 polymorphism provokes loss of chemotaxis (17) or 
increases adherence to its ligand (19). Here, the presence of bound 
CX3CL1 significantly inhibited the CCL2-dependent chemotaxis 
of monocytes expressing the CX3CR1 M280 variant (Figure 2). If 
similar alterations occur in vivo to retinal MCs, the M280 polymor-
phism may cause excessive MC adherence to membrane-anchored 
CX3CL1 and reduce migration in response to other inflammatory 
chemoattractants. Over the years, in subjects with the M280 poly-
morphism, clearance of MCs from the subretinal space (in response 
Figure 4
SrMC accumulation induces retinal degeneration in albino CX3CR1–/– mice. (A 
and B) RPE flatmounts of albino CX3CR1+/+ BALB/c (A) and CX3CR1–/– BALB/c 
mice (B) showed more numerous CD11b-positive (green) SrMC abutting the RPE 
(Phalloidin, red) in CX3CR1-deficient animals. (C) Quantification of subretinal 
CD11b-positive cells on RPE flatmounts revealed a significantly higher density of 
MCs in CX3CR1–/– mice at 1 and 2 months of age raised in ambient light condi-
tions. CX3CR1–/– BALB/c mice raised in complete darkness showed significantly 
fewer SrMC than ambient light–raised CX3CR1–/– BALB/c mice. (D–F) Toluidine 
blue–stained epoxy retinal semithin sections showed complete degeneration of all 
photoreceptors in albino CX3CR1–/– BALB/c mice (E) at 4 months of age compared 
with CX3CR1+/+ BALB/c mice (D). This degeneration was prevented in CX3CR1–/– 
BALB/c mice raised in darkness (F). (G) Measurements of photoreceptor cell layer 
thickness showed significant and progressive degeneration in albino CX3CR1–/– 
BALB/c mice, which was completely reversed by raising CX3CR1–/– BALB/c mice 
in darkness. Experiments were performed on 8–10 eyes from different mice per 
group. *P < 0.05. Scale bars: 50 μm.
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to soluble CX3CL1 or other chemoattractants) would thereby be 
inhibited, and SrMC accumulation might occur.
To simulate CX3CR1 dysfunction in an animal model, we used 
2 independently generated CX3CR1 knockout mouse strains. 
Our data demonstrated strong and persistent SrMC accumu-
lation in CX3CR1-deficient mice in 3 experimental conditions: 
laser injury, aging, and albino animals. In contrast, control mice 
with laser injury only transiently amassed ramified F4/80- and 
GFP-positive cells, and aging and albino control animals slowly 
or steadily accumulated SrMCs. We and others have previously 
demonstrated that CX3CR1 deficiency reduces macrophage 
aggregation in atherosclerotic lesions (20, 29), probably by limit-
ing monocyte recruitment from the blood. In view of the role of 
CX3CR1 in monocyte recruitment, the excessive number of MCs 
observed in CX3CR1-deficient mice is unlikely to be the result of 
an excessive influx of monocytes.
Unlike the monocytes in atherosclerotic lesions, MCs can prolif-
erate in situ (30). Their accumulation may be the result of exces-
sive proliferation or inhibition of their clearance from the 
subretinal space. CX3CL1, however, has been shown to facili-
tate microglia proliferation (31), and excessive proliferation is 
unlikely to occur in CX3CR1 deficiency. On the other hand, 
SrMC clearance by apoptosis or migration (egression) may be 
affected by abrogation of CX3CR1. This question is currently 
under investigation in our laboratory.
Interestingly, CCL2 and CCR2 signaling did not appear to 
be involved in retinal MC distribution. Although CCL2–/– (and 
CCR2–/–) mice have previously been shown to develop signs 
of AMD secondary to a macrophage recruitment deficit (11), 
they did not develop significant SrMC accumulation (1.7 ± 0.2 
SrMCs/mm2) at 12 months of age in the present study. The 
macrophage-dependent debris clearance (11) may play a role 
only at a more advanced stage of the disease.
In CX3CR1-deficient mice, the resulting prolonged presence 
of MCs in the subretinal space was associated with excessive 
OS phagocytosis by SrMCs, which subsequently accumulated 
intracellular lipids. These subretinal microglial foam cells were the 
origin of the drusen-like deposits in mice. Similarly, in humans, 
we found CX3CR1-positive bloated SrMCs in the eyes of individu-
als with AMD (Figure 1B), and others have previously shown that 
clearance of photoreceptor debris by activated MCs causes bloated 
SrMCs (15). It is tempting to speculate that SrMCs contribute to 
some extent to the drusen formation in AMD and that the rounded 
contours and steeply sloping sides characteristic of drusen (5) may 
derive in part from degenerating bloated MCs that are subsequently 
covered by RPE cells. Supporting this theory is the fact that dru-
sen contain numerous degenerating organelles, the origin of which 
may be retinal MCs (32). Moreover, CX3CR1 deposits were found 
in drusen (Figure 1F). Similar drusen deposits have previously been 
reported to contain apolipoprotein E, complement factors, MHC, 
and amyloid oligomers, among others (5, 33–36). When activated, 
MCs can express ApoE (37), complement factors (38), MHC (39), 
and the β-amyloid precursor protein (40) as well as CX3CR1. MCs 
can be a major source of oxidative stress through respiratory bursts 
Figure 5
Drusen observed in CX3CR1 knockout animals are bloated SrMCs. 
(A–D) Comparison of fundus photos and micrographs of a RPE 
flatmount in tangential light of 1-year-old CX3CR1+/+ (A and C) and 
CX3CR1–/– mice (B and D) revealed multiple drusen in CX3CR1–/– 
mice. (E–G) Higher-magnification image of a drusen (arrow) in a 
CX3CR1GFP/GFP mouse in tangential light (E) superimposed with 
GFP-positive (green; red, Phalloidin; blue, DAPI) subretinal rami-
fied cells (F) on RPE flatmounts. Merge of tangential light and DAPI 
is shown in G. (H and I) GFP-positive subretinal ramified cells (H) 
on CX3CR1GFP/GFP RPE flatmounts were positive for the MC marker 
5D4 (red, I). (J and K) Histological sections of historesin-embed-
ded 12-month-old CX3CR1+/+ (J) and CX3CR1–/– (K) eyes showed 
subretinal cells abutting the RPE in CX3CR1–/– (K, arrow) but not in 
CX3CR1+/+ mice. (L) Electron microscopy of the RPE/OS interface 
in CX3CR1–/– mice revealed subretinal cells (asterisk) with multiple 
phagosomes juxtaposed to the RPE cell layer. (M) Higher magnifi-
cation of these subretinal cells revealed multiple lipid deposits and 
typical remnants of rod OSs in phagosomes (arrow). (N) Subretinal 
CD11b-positive (green) dendritic cells contained rhodopsin-positive 
inclusions (red) in confocal micrographs of RPE flatmounts from 
CX3CR1–/– mice. Results are representative of at least 3 indepen-
dent experiments. Scale bars: 500 μm (A–D), 50 μm (E–G), 20 μm 
(H–K and N), 1 μm (L and M).
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(41) that can cause the oxidative protein and lipid modifications 
associated with drusen. The inflammatory proteins found in drusen 
may therefore be of retinal MC origin, at least in part.
Another consequence of the prolonged presence of MCs in the 
subretinal space may be photoreceptor cell death. In CX3CR1–/– 
mice, retinal degeneration was observed in senescent mice, in 
albino mice, and in the vicinity of subretinal neovascularization. 
The retinal degeneration in CX3CR1–/– mice was always preced-
ed by SrMC accumulation and could be averted by limiting MC 
accumulation in the subretinal space, as seen in CX3CR1–/– albi-
no mice raised in the dark (Figure 4). SrMC accumulation was 
observed as early as 6 months of age in pigmented and 1 month 
in albino CX3CR1-deficient mice, before any significant retinal 
degeneration (data not shown). There are no naturally occurring 
mutations known to cause retinal degeneration in BALB/c mice, 
and the time course of the degeneration, starting at 2 months, did 
not match any known retinal degeneration caused by photorecep-
tor or RPE gene defects. We further note that neither photore-
ceptors nor RPE cells contained express CX3CR1. Activated MCs 
participate in ganglion cell death in vivo (42) and can induce pho-
toreceptor cell death in vitro (43). Neuronal cell toxicity caused 
by the prolonged presence of MCs (CX3CR1GFP/GFP) in the brain 
has previously been described as a mechanism of neurodegenera-
tive diseases (14), and similar mechanisms may cause the degen-
eration observed in the CX3CR1–/– BALB/c mice, in the senes-
cent CX3CR1–/– C57BL/6 mice, and in the vicinity of subretinal 
neovascularization after laser injury. To recapitulate, 
SrMC accumulation in CX3CR1-deficient mice is asso-
ciated with photoreceptor degeneration in the absence 
of any primary photoreceptor or RPE disease. To our 
knowledge, no such mechanism of retinal degenera-
tion has previously been described.
Furthermore, we showed that activated SrMCs adjacent to the 
laser injury site express VEGF. In CX3CR1-deficient mice, the 
increased accumulation of SrMCs and subsequent secretion of 
VEGF may be responsible for the development of the exaggerated 
neovascularization. This is consistent with our previous work, 
which showed that MCs can develop proangiogenic properties in 
the retina (44). Moreover, CX3CR1-positive MCs were found in 
human CNV, which indicates that SrMCs are a possible cause or 
aggravating factor for CNV in AMD.
In summary, our results suggest that MC accumulation in the 
subretinal space may be a driving force in the pathogenesis of 
AMD and not a mere consequence of primary RPE or photorecep-
tor disease. Our study challenges the long-standing paradigm of 
drusen genesis as the gradual accumulation of extracellular debris 
from the RPE and choroid. We propose that SrMC accumulation, 
resulting from a migratory defect associated with CX3CR1, plays 
a key role in drusen formation, CNV, and retinal degeneration, the 
main features of AMD.
Methods
Study participants and AMD assessment. The GAMD study included 285 par-
ticipants (29% men) recruited in the “Centre d’angiographie et de laser” dur-
ing the second trimester of 2006. AMD was diagnosed in all participants by 
2 independent ophthalmologists. The DETER study included 520 blood 
donors (56% men) recruited during 2003–2005 at the blood bank of the 
Figure 6
SrMCs accumulate after laser injury, exacerbate neovas-
cularization, and induce adjacent retinal degeneration. (A 
and B) At 3 months of age, CX3CR1+/GFP mice displayed 
some GFP-positive (green) SrMCs adjacent to the CNV 
(red, Griffonia simplicifolia) 14 days after laser injury (A), 
and CX3CR1GFP/GFP mice showed strong SrMC accu-
mulation (B). (C) CX3CR1+/GFP mice showed a transient 
increase of SrMCs after laser impact, peaking at day 7; 
however, SrMCs in CX3CR1GFP/GFP mice were significantly 
more numerous at that time and continued to accumulate. 
(D–F) Immunohistochemistry at day 7 revealed VEGF 
expression (green) in F4/80-positive activated CX3CR1+/+ 
MCs (red) in the subretinal space. Nuclei were stained with 
DAPI (blue). (G and H) Micrographs of fluorescein dextran 
(green) perfused RPE/choroidal flatmounts double labeled 
with endothelial cell marker Griffonia simplicifolia (red) 14 
days after laser impact in CX3CR1+/+ (G) and CX3CR1–/– 
(H) mice showed representative CNV. (I) Quantification 
showed exacerbated neovascularization in the knock-
out strains. (J) Eyes of CX3CR1+/+ mice (12 months old) 
showed a normal photoreceptor cell layer 200 μm adja-
cent to the impact 21 days after laser treatment. (K) At 
this stage CX3CR1–/– mice displayed SrMCs and a thinned 
and irregular photoreceptor cell layer. (L) Laser-dependent 
retinal degeneration (calculated as described in Methods) 
was significantly more pronounced in CX3CR1–/– mice only 
at 100 and 200 μm. Experiments were performed on 8–10 
eyes from different mice per group. *P < 0.05. Scale bars: 
50 μm (A, B, G, H, J, and K), 10 μm (D–F).
research article
 The Journal of Clinical Investigation   http://www.jci.org   Volume 117   Number 10   October 2007 2927
Hospitalier Pitié-Salpétrière (P. Deterre, unpublished observations). In 
accordance with the Declaration of Helsinki, patients and volunteers pro-
vided written and informed consent for the GAMD and DETER studies, 
which were approved by the Pitié-Salpétrière and Hotel-Dieu (Paris, France) 
ethics committees (no. 0611303). Genomic DNA was extracted from EDTA 
anticoagulated venous blood with the DNeasy kit (Qiagen), following the 
manufacturer’s standard protocols. Previously published studies were used 
as references: the ECTIM study (16), the Offspring Cohort of the FHS (17), 
and the GENIC study (18). The ECTIM study is a case-control study specially 
designed to identify genetic variants associated with myocardial infarc-
tion. The study targeted 4 populations covered by CHD registries (WHO/ 
MONICA): 3 in France, in the regions of Lille, Strasbourg, and Toulouse, 
and 1 in Northern Ireland, in the region of Belfast. GENIC is a case-control 
study of cerebrovascular stroke, conducted in collaboration with a French 
network of specialized clinical departments. The Offspring Cohort of the 
FHS began in 1971, enrolling 5,124 children and children-in-law of the 
original participants. They undergo a comprehensive medical exam every 4 
years (defined as a cycle). The FHS Offspring Cohort contained 1,888 unre-
lated participants for whom DNA was available. Of these, 1,861 had given 
informed consent for genotyping and were entered into the present study.
Screening for polymorphisms. CX3CR1 polymorphisms were identified with 
Minor Groove Binder PCR-based amplification technology from Perkin-
Elmer (Applied Biosystems), as described elsewhere (45).
Human eye sections. Eyes from 4 patients with AMD (3 dry and 1 wet form) 
and 3 age-matched control donors were obtained from the eye bank of 
Quebec. The maculae were dissected, fixed in PBS with 4% paraformaldehyde 
(PFA), frozen, and sectioned (10 μm). Patients and volunteers gave 
informed consent in accordance with Quebec’s ethics regulations.
Chemotactic migration assay. PBMCs were isolated from heparinized venous 
blood from healthy volunteer individuals by 1-step centrifugation on a Ficoll 
separating solution (Eurobio), washed twice with PBS, and resuspended at 
5 × 106 cells/ml in serum-free DMEM (Invitrogen) containing 5 mg/ml of 
bovine serum albumin. Chemotaxis was assayed in a 24-well chemotaxis 
chamber through transwell filters (Corning Incorporated). Filters (8-μm pore 
size) were treated with anti-histidine antibody (5 μg/ml) for 2 hours at room 
temperature, washed with PBS, and coated with CX3CL1-Histidine (0.1 μg/
ml) or PBS overnight at 4°C. After the filters were rinsed with PBS, 100 μl of 
cell suspension was loaded onto the filter. CCL2 (100 nM) or PBS was placed 
in the lower chamber. The plate was then incubated for 3 h at 37°C, 100% 
humidity, and 5% CO2. Monocytes that had migrated through the bottom 
surface of the filters were then counted by flow cytometry (FACSCalibur; BD) 
based on CD14 expression (BD Biosciences). The mean number of monocytes 
in triplicate samples was determined, and a chemotactic index — or ratio 
of cells in the lower chamber with and without CCL2 — was calculated for 
monocytes migrating through filters with or without a CX3CL1 coating.
Animals. CX3CR1–/– and CX3CR1GFP/GFP mouse strains on C57BL/6 
background and their controls were generated as described previously (20, 
23). CX3CR1–/– C57BL/6 mice were backcrossed for 6 generations into 
the BALB/c background (Janvier) to obtain the CX3CR1–/– BALB/c strain 
and kept in specific pathogen–free conditions with food and water avail-
able ad libitum and housed in a 12-h light/12-h dark (100–500 lux) cycle 
or in complete darkness (CX3CR1–/– BALB/c). Animal experiments were 
approved by the local Institutional Animal Care and Use Committee: Cen-
tre d’Exploration Fonctionelle, Pitié-Salpétrière.
Fundus photography and laser-coagulation. Mice were anesthetized by intra-
muscular injection of ketamine (50 mg/kg) and xylazine (10 mg/kg). Pupils 
were fully dilated with 1% tropicamide or 1% atropin. Coverslips positioned 
on the mouse cornea were used as a contact glass. Fundus photographs 
were taken with a digital camera mounted on an ophthalmic operating 
microscope (Zeiss). Laser coagulations were performed 1–2 disc diameters 
away from the papillae with an Argon laser (532 nm) mounted on a slit 
lamp (400 mW, 50 ms and 50 μm).
Immunohistochemistry. Frozen sections were stained according to previ-
ously described standard immunohistochemical procedures (44). Primary 
antibodies used were rabbit polyclonal anti-human CX3CR1 (Chemicon), 
mouse anti-human CD18 (BD Biosciences — Pharmingen), rat monoclo-
nal anti-CD11b (Serotec), rat anti-F4/80 (BD Biosciences — Pharmingen), 
mouse anti-rat keratan sulfate proteoglycan (5D4, Seikagaku), mouse 
anti-GFP (Torrey Pines Biolabs), VEGF (Chemicon), and goat anti-mouse 
CX3CL1 (R&D). Lectins used were TRITC-conjugated Lectin Ulex Euro-
paeus or Griffonia simplicifolia (Sigma-Aldrich) and Rhodamine Phalloidin 
(Invitrogen). The corresponding Alexa or alkaline phosphatase–conju-
gated secondary antibodies (Invitrogen) were used to reveal the primary 
antibodies, and sections were counterstained with DAPI or hemalun. Alka-
line phosphatase was revealed with fast red (Sigma-Aldrich). Sections and 
flatmounts were viewed with a fluorescence microscope (BX51; Olympus) 
or a confocal microscope (LSM 510 laser scanning microscope; Zeiss). All 
immunostaining was repeated at least 3 times, and staining that omitted 
the primary antibody served as a negative control.
Choroidal flatmounts and SrMC/CNV quantifications. Eyes were enucleated, 
fixed in 4% PFA for 15 minutes at room temperature, and sectioned at the 
limbus; the cornea and lens were discarded (for CNV, mice were perfused with 
Fluorescein Dextran 106 before enucleation). The retinas were carefully peeled 
from the RPE/choroid/sclera. Retinas and choroids were fixed for an addi-
tional 15 minutes in methanol at –20°C and incubated with the indicated 
primary and secondary antibodies and lectins. The choroids and retinas were 
radially incised, flatmounted, and viewed with a fluorescence microscope 
(BX51; Olympus). For RPE flatmount photographs, tangential white light was 
applied by placing the light-conducting glass fibers of a KL2500LCD Schott 
lamp directly over the coverslip, next to the objective. SrMC were counted on 
GFP or F4/80 stained whole RPE/choroidal flatmounts up to the ciliary body 
and on the OS side of the retina. The surface of the RPE was measured and 
SrMC density calculated. CNV was measured on photographs with Image J 
analysis software. Retinal degeneration was assessed on historesin-embedded 
sections (see below) that crossed the center of the laser impact.
Histology and electron microscopy. For histology, eyes were fixed in 0.5% glu-
taraldehyde, 4% PFA PBS for 2 h, dehydrated, and mounted in historesin. 
Sections (5 μm) were cut and stained with eosin. For electron microscopy 
and semithin sections, eyes were fixed in 2.5% glutaraldehyde of cacodyl-
ate buffer (0.1 M, pH 7.4). After 1 hour, eyeballs were dissected, fixed for 
another 3 hours, postfixed in 1% osmium tetroxide in cacodylate buffer, 
and dehydrated in graduated ethanol solution. The samples were includ-
ed in epoxy resin and oriented. Semithin sections (1 μm) were sliced with 
an ultramicrotome Reichert Ultracut E (Leica), stained by toluidine blue, 
and examined with a light microscope to measure the photoreceptor layer 
thickness. Multiple measurements of the photoreceptor cell layer of injured 
and uninjured retina were used to calculate the relative retinal thicknesses 
at sites 100–1,000 μm from the site of laser impact. Ultrathin sections (80 
nm) were stained for contrast with uranyl acetate and lead citrate and were 
observed in a JEOL 100 CX II electron microscope (JEOL) with 80 kV. The 
absolute values of outer nuclear layer thickness of epoxy-embedded semithin 
and historesin-embedded sections were not comparable because of stronger 
shrinkage for the former.
Statistics. Allelic frequencies were calculated by gene counting. Hardy-Wein-
berg equilibrium was tested with the χ2 test with 1 degree of freedom. We used 
the χ2 test to compare genotype distributions and allele frequencies in par-
ticipants. Statistical comparisons used unpaired 2-sample t tests for means 
and Mann-Whitney U tests. All analyses and graphic representation were per-
formed with Prism software (version 4.0c; GraphPad Software), and values are 
reported as mean ± SEM. A P value less than 0.05 was considered significant.
research article
2928 The Journal of Clinical Investigation   http://www.jci.org   Volume 117   Number 10   October 2007
Acknowledgments
The authors wish to thank Arnaud Cangialosi, Christophe Klein, 
and Stéphanie Girard for technical assistance and Myriam Gort 
(Centre d’Exploration Fonctionnelle animal facility, Pitié-Salpé-
trière). We thank D. Littman and S. Jung for sharing the CX3CR1Kin 
GFP mice and R.S. Molday for the anti-rhodospsin antibody. This 
work was supported by grants from INSERM, by ANR grant “Car-
diovasculaire, obésité et diabète” (AO5088DS), by ANR grant 
“blanc” (AO5120DD), by European Grant “Innochem” 518167, by 
PNR vision (AO6004SP), and by the FONDATION NRJ-Institut de 
France. C. Combadière is the recipient of a contract “Interface” from 
Assistance Publiques-Hopitaux de Paris, and M. Rodéro is support-
ed by a studentship from the Canceropole Île de France.
Received for publication February 2, 2007, and accepted in revised 
form June 26, 2007.
Address correspondence to: Florian Sennlaub, INSERM U872, 
Centre de recherche des Cordeliers, 15 rue de l’Ecole de Médecine, 
75006 Paris, France. Phone: 33-1-40-46-78-63; Fax: 33-1-40-46-
78-65; E-mail: sennlaub@idf.inserm.fr. Or to: Christophe Com-
badière, INSERM U543, Faculté de Médecine Pitié-Salpétrière, 91 
Boulevard de l’Hôpital, 75013 Paris, France. Phone: 33-1-40-77-98-
92; Fax: 33-1-40-77-97-34; E-mail: combad@ccr.jussieu.fr.
Christophe Combadière, Charles Feumi, and William Raoul con-
tributed equally to this work.
 1. Friedman, D.S., et al. 2004. Prevalence of age-relat-
ed macular degeneration in the United States. Arch. 
Ophthalmol. 122:564–572.
 2. Sarks, S.H. 1976. Ageing and degeneration in the 
macular region: a clinico-pathological study. Br. J. 
Ophthalmol. 60:324–341.
 3. Bird, A.C., et al. 1995. An international classifica-
tion and grading system for age-related maculopa-
thy and age-related macular degeneration. The 
International ARM Epidemiological Study Group. 
Surv. Ophthalmol. 39:367–374.
 4. Farkas, T.G., Sylvester, V., Archer, D., and Altona, 
M. 1971. The histochemistry of drusen. Am. J. Oph-
thalmol. 71:1206–1215.
 5. Hageman, G.S., et al. 2001. An integrated hypothe-
sis that considers drusen as biomarkers of immune-
mediated processes at the RPE-Bruch’s membrane 
interface in aging and age-related macular degen-
eration. Prog. Retin. Eye Res. 20:705–732.
 6. Souied, E.H., et al. 1998. The epsilon4 allele of the 
apolipoprotein E gene as a potential protective fac-
tor for exudative age-related macular degeneration. 
Am. J. Ophthalmol. 125:353–359.
 7. Kimura, K., Isashiki, Y., Sonoda, S., Kakiuchi-Mat-
sumoto, T., and Ohba, N. 2000. Genetic association 
of manganese superoxide dismutase with exudative 
age-related macular degeneration. Am. J. Ophthal-
mol. 130:769–773.
 8. Haines, J.L., et al. 2005. Complement factor H vari-
ant increases the risk of age-related macular degen-
eration. Science. 308:419–421.
 9. Edwards, A.O., et al. 2005. Complement factor H 
polymorphism and age-related macular degenera-
tion. Science. 308:421–424.
 10. Tuo, J., et al. 2004. The involvement of sequence vari-
ation and expression of CX3CR1 in the pathogen-
esis of age-related macular degeneration. FASEB J. 
18:1297–1299.
 11. Ambati, J., et al. 2003. An animal model of age-
related macular degeneration in senescent Ccl-2- or 
Ccr-2-deficient mice. Nat. Med. 9:1390–1397.
 12. Tsutsumi, C., et al. 2003. The critical role of ocu-
lar-infiltrating macrophages in the development 
of choroidal neovascularization. J. Leukoc. Biol. 
74:25–32.
 13. Geissmann, F., Jung, S., and Littman, D.R. 2003. 
Blood monocytes consist of two principal sub-
sets with distinct migratory properties. Immunity. 
19:71–82.
 14. Cardona, A.E., et al. 2006. Control of microglial 
neurotoxicity by the fractalkine receptor. Nat. Neu-
rosci. 9:917–924.
 15. Gupta, N., Brown, K.E., and Milam, A.H. 2003. 
Activated microglia in human retinitis pigmentosa, 
late-onset retinal degeneration, and age-related 
macular degeneration. Exp. Eye Res. 76:463–471.
 16. Georges, J.L., et al. 2001. Interleukin-6 gene poly-
morphisms and susceptibility to myocardial 
infarction: the ECTIM study. Etude Cas Temoin de 
l’Infarctus du Myocarde. J. Mol. Med. 79:300–305.
 17. Kannel, W.B., Feinleib, M., McNamara, P.M., Garri-
son, R.J., and Castelli, W.P. 1979. An investigation of 
coronary heart disease in families: the Framingham 
offspring study. Am. J. Epidemiol. 110:291–290.
 18. Touboul, P.-J., et al. 2000. Common carotid artery inti-
ma-media thickness and brain infarction: the Etude 
du Profil Génétique de l’Infarctus Cérébral (GENIC) 
case-control study. Circulation. 102:313–318.
 19. Daoudi, M., et al. 2004. Enhanced adhesive capaci-
ties of the naturally occurring Ile249-Met280 vari-
ant of the chemokine receptor CX3CR1. J. Biol. 
Chem. 279:19649–19657.
 20. Combadiere, C., et al. 2003. Decreased atheroscle-
rotic lesion formation in CX3CR1/apolipoprotein E 
double knockout mice. Circulation. 107:1009–1016.
 21. Ng, T.F., and Streilein, J.W. 2001. Light-induced 
migration of retinal microglia into the subretinal 
space. Invest. Ophthalmol. Vis. Sci. 42:3301–3310.
 22. Margrain, T.H., Boulton, M., Marshall, J., and 
Sliney, D.H. 2004. Do blue light filters confer pro-
tection against age-related macular degeneration? 
Prog. Retin. Eye Res. 23:523–531.
 23. Jung, S., et al. 2000. Analysis of fractalkine receptor 
CX(3)CR1 function by targeted deletion and green 
fluorescent protein reporter gene insertion. Mol. 
Cell. Biol. 20:4106–4114.
 24. Tamai, M., and O’Brien, P.J. 1979. Retinal dystro-
phy in the RCS rat: in vivo and in vitro studies of 
phagocytic action of the pigment epithelium on the 
shed rod outer segments. Exp. Eye Res. 28:399–411.
 25. Caicedo, A., Espinosa-Heidmann, D.G., Pina, Y., 
Hernandez, E.P., and Cousins, S.W. 2005. Blood-
derived macrophages infiltrate the retina and acti-
vate Muller glial cells under experimental choroidal 
neovascularization. Exp. Eye Res. 81:38–47.
 26. Nishiyori, A., et al. 1998. Localization of fractalkine 
and CX3CR1 mRNAs in rat brain: does fractalkine 
play a role in signaling from neuron to microglia? 
FEBS Lett. 429:167–172.
 27. Silverman, M.D., et al. 2003. Constitutive and 
inflammatory mediator-regulated fractalkine 
expression in human ocular tissues and cultured 
cells. Invest. Ophthalmol. Vis. Sci. 44:1608–1615.
 28. Higgins, G.T., Wang, J.H., Dockery, P., Cleary, P.E., 
and Redmond, H.P. 2003. Induction of angiogenic 
cytokine expression in cultured RPE by ingestion 
of oxidized photoreceptor outer segments. Invest. 
Ophthalmol. Vis. Sci. 44:1775–1782.
 29. Lesnik, P., Haskell, C.A., and Charo, I.F. 2003. 
Decreased atherosclerosis in CX3CR1–/– mice 
reveals a role for fractalkine in atherogenesis. J. Clin. 
Invest. 111:333–340. doi:10.1172/JCI200315555.
 30. Zeiss, C.J., and Johnson, E.A. 2004. Proliferation 
of microglia, but not photoreceptors, in the outer 
nuclear layer of the rd-1 mouse. Invest. Ophthalmol. 
Vis. Sci. 45:971–976.
 31. Hatori, K., Nagai, A., Heisel, R., Ryu, J.K., and Kim, S.U. 
2002. Fractalkine and fractalkine receptors in human 
neurons and glial cells. J. Neurosci. Res. 69:418–426.
 32. Farkas, T.G., Sylvester, V., and Archer, D. 1971. 
The ultrastructure of drusen. Am. J. Ophthalmol. 
71:1196–1205.
 33. van der Schaft, T.L., Mooy, C.M., de Bruijn, W.C., and 
de Jong, P.T. 1993. Early stages of age-related macular 
degeneration: an immunofluorescence and electron 
microscopy study. Br. J. Ophthalmol. 77:657–661.
 34. Mullins, R.F., Russell, S.R., Anderson, D.H., and 
Hageman, G.S. 2000. Drusen associated with aging 
and age-related macular degeneration contain pro-
teins common to extracellular deposits associated 
with atherosclerosis, elastosis, amyloidosis, and 
dense deposit disease. FASEB J. 14:835–846.
 35. Luibl, V., et al. 2006. Drusen deposits associated 
with aging and age-related macular degeneration 
contain nonfibrillar amyloid oligomers. J. Clin. 
Invest. 116:378–385. doi:10.1172/JCI25843.
 36. Johnson, L.V., et al. 2002. The Alzheimer’s A beta-
peptide is deposited at sites of complement activa-
tion in pathologic deposits associated with aging 
and age-related macular degeneration. Proc. Natl. 
Acad. Sci. U. S. A. 99:11830–11835.
 37. Xu, Q., et al. 2006. Profile and regulation of 
apolipoprotein E (ApoE) expression in the CNS in 
mice with targeting of green fluorescent protein 
gene to the ApoE locus. J. Neurosci. 26:4985–4994.
 38. Bellander, B.M., Bendel, O., Von Euler, G., Ohlsson, 
M., and Svensson, M. 2004. Activation of microgli-
al cells and complement following traumatic injury 
in rat entorhinal-hippocampal slice cultures. J. Neu-
rotrauma. 21:605–615.
 39. Matsubara, T., Pararajasegaram, G., Wu, G.S., 
and Rao, N.A. 1999. Retinal microglia differen-
tially express phenotypic markers of antigen-pre-
senting cells in vitro. Invest. Ophthalmol. Vis. Sci. 
40:3186–3193.
 40. Haass, C., Hung, A.Y., and Selkoe, D.J. 1991. Process-
ing of beta-amyloid precursor protein in microglia 
and astrocytes favors an internal localization over 
constitutive secretion. J. Neurosci. 11:3783–3793.
 41. Klegeris, A., and McGeer, P.L. 1994. Rat brain 
microglia and peritoneal macrophages show 
similar responses to respiratory burst stimulants. 
J. Neuroimmunol. 53:83–90.
 42. Thanos, S., Mey, J., and Wild, M. 1993. Treatment 
of the adult retina with microglia-suppressing fac-
tors retards axotomy-induced neuronal degrada-
tion and enhances axonal regeneration in vivo and 
in vitro. J. Neurosci. 13:455–466.
 43. Roque, R.S., Rosales, A.A., Jingjing, L., Agarwal, N., 
and Al-Ubaidi, M.R. 1999. Retina-derived microg-
lial cells induce photoreceptor cell death in vitro. 
Brain Res. 836:110–119.
 44. Checchin, D., Sennlaub, F., Levavasseur, E., Leduc, 
M., and Chemtob, S. 2006. Potential role of 
microglia in retinal blood vessel formation. Invest. 
Ophthalmol. Vis. Sci. 47:3595–3602.
 45. Lavergne, E., et al. 2004. Intratumoral CC chemo-
kine ligand 5 overexpression delays tumor growth 
and increases tumor cell infiltration. J. Immunol. 
173:3755–3762.
